December 2017

Greyrock provides Altus Capital with $10.9 million in subordinated debt and equity to back its acquisition of MGC Diagnostics, a global medical technology company that develops, manufactures and markets non-invasive diagnostic systems for the detection, classification and management of cardiorespiratory disease.